Please use this identifier to cite or link to this item:
標題: 肝臟手術病人基礎低鎂血症的發生率和危險因素
Incidence and risk factors of baseline hypomagnesemia in patients undergoing liver surgery
作者: 籃國懋
Kuo-Mao Lan
關鍵字: 低血鎂
liver surgery
引用: 1. Lecube A, Baena-Fustegueras JA, Fort JM, Pelegrí D, Hernández C, Simó R. Diabetes is the main factor accounting for hypomagnesemia in obese subjects. PLoS One. 2012;7: e30599. doi:10.1371/journal.pone.0030599 2. Iseri LT, French JH. Magnesium: nature's physiologic calcium blocker. Am Heart J. 1984;108: 188–193. Available: 3. De Baaij JHF, Hoenderop JGJ, Bindels RJM. Regulation of magnesium balance: lessons learned from human genetic disease. Clin Kidney J. 2012;5: i15–i24. 4. Buri A, McGuigan JA. Intracellular free magnesium and its regulation, studied in isolated ferret ventricular muscle with ion-selective microelectrodes. Exp Physiol. 1990;75: 751–761. doi:10.1113/expphysiol.1990.sp003457 5. Whang R, Hampton EM, Whang DD. Magnesium Homeostasis and Clinical Disorders of Magnesium Deficiency. Ann Pharmacother. 1994;28: 220–226. doi:10.1177/106002809402800213 6. Ayuk J, Gittoes NJL. Contemporary view of the clinical relevance of magnesium homeostasis. Ann Clin Biochem. 03/2014;51: 179–188. doi:10.1177/0004563213517628 7. Elin RJ. Magnesium metabolism in health and disease. Dis Mon. 1988;34: 161–218. Available: 8. Weast RC, Astle MJ, Beyer WH. CRC Handbook of Chemistry and Physics [Internet]. 1988. Available: 9. Jahnen-Dechent W, Ketteler M. Magnesium basics. Clin Kidney J. 2012;5: i3–i14. doi:10.1093/ndtplus/sfr163 10. Maguire ME, Cowan JA. Magnesium chemistry and biochemistry. Biometals. 2002;15: 203–210. 11. Wacker WEC. Magnesium and Man [Internet]. Harvard University Press; 1980. doi:10.4159/harvard.9780674366374 12. Saris NE, Mervaala E, Karppanen H, Khawaja JA, Lewenstam A. Magnesium. An update on physiological, clinical and analytical aspects. Clin Chim Acta. 2000;294: 1–26. Available: 13. Fine KD, Santa Ana CA, Porter JL, Fordtran JS. Intestinal absorption of magnesium from food and supplements. J Clin Invest. 1991;88: 396–402. doi:10.1172/JCI115317 14. Saris N-EL, Mervaala E, Karppanen H, Khawaja JA, Lewenstam A. Magnesium. Clin Chim Acta. 2000;294: 1–26. doi:10.1016/s0009-8981(99)00258-2 15. Konrad M, Schlingmann KP, Gudermann T. Insights into the molecular nature of magnesium homeostasis. American Journal of Physiology-Renal Physiology. 2004;286: F599–F605. 16. Elin RJ. Assessment of magnesium status for diagnosis and therapy. Magnes Res. 2010;23: 194–198. Available: 17. Kokko JP, Tannen RL. Fluids and Electrolytes [Internet]. W.B. Saunders Company; 1996. Available: 18. Touyz RM. Magnesium in clinical medicine. Front Biosci. 2004;9: 1278–1293. Available: 19. Assadi F. Hypomagnesemia: an evidence-based approach to clinical cases. Iran J Kidney Dis. 2010;4: 13. Available: 20. Fawcett WJ, Haxby EJ, Male DA. Magnesium: physiology and pharmacology. Br J Anaesth. 1999;83: 302–320. doi:10.1093/bja/83.2.302 21. Gums JG. Magnesium in cardiovascular and other disorders. Am J Health Syst Pharm. 2004;61: 1569–1576. Available: 22. Swaminathan R. Magnesium metabolism and its disorders. Clin Biochem Rev. 2003;24: 47. Available: 23. Ryan MF. The role of magnesium in clinical biochemistry: an overview. Ann Clin Biochem. 1991;28 ( Pt 1): 19–26. doi:10.1177/000456329102800103 24. Romani AMP. Magnesium in Health and Disease. Interrelations between Essential Metal Ions and Human Diseases. Springer, Dordrecht; 2013. pp. 49–79. doi:10.1007/978-94-007-7500-8_3 25. Topf JM, Murray PT. Hypomagnesemia and hypermagnesemia. Rev Endocr Metab Disord. 2003;4: 195–206. Available: 26. Aikawa JK. Magnesium: its biologic significance [Internet]. CRC; 1981. Available: 27. Marier JR. Magnesium content of the food supply in the modern-day world. Magnesium. 1986;5: 1–8. Available: 28. Blumberg JB, Frei B, Fulgoni VL, Weaver CM, Zeisel SH. Contribution of Dietary Supplements to Nutritional Adequacy in Various Adult Age Groups. Nutrients. 2017;9. doi:10.3390/nu9121325 29. Institute of Medicine (US) Standing Committee on the Scientific Evaluation of Dietary Reference Intakes. Dietary Reference Intakes for Calcium, Phosphorus, Magnesium, Vitamin D, and Fluoride [Internet]. Washington (DC): National Academies Press (US); 2012. doi:10.17226/5776 30. Ayuk J, Gittoes NJL. How should hypomagnesaemia be investigated and treated? Clin Endocrinol . 2011;75: 743–746. doi:10.1111/j.1365-2265.2011.04092.x 31. Mouw DR, Latessa RA, Hickner J. Clinical inquiries. What are the causes of hypomagnesemia? J Fam Pract. 2005;54: 174–176. Available: 32. Agus ZS. Hypomagnesemia. J Am Soc Nephrol. 1999;10: 1616–1622. Available: 33. Hashizume N, Mori M. An analysis of hypermagnesemia and hypomagnesemia. Jpn J Med. 1990;29: 368–372. Available: 34. Chernow B, Bamberger S, Stoiko M, Vadnais M, Mills S, Hoellerich V, et al. Hypomagnesemia in patients in postoperative intensive care. Chest. 1989;95: 391–397. Available: 35. Elin RJ. Magnesium metabolism in health and disease. Dis Mon. 1988;34: 161–218. Available: 36. Musso CG. Magnesium metabolism in health and disease. Int Urol Nephrol. 2009;41: 357–362. doi:10.1007/s11255-009-9548-7 37. Whang R, Ryder KW. Frequency of hypomagnesemia and hypermagnesemia. Requested vs routine. JAMA. 1990;263: 3063–3064. Available: 38. Wahr JA, Parks R, Boisvert D, Comunale M, Fabian J, Ramsay J, et al. Preoperative Serum Potassium Levels and Perioperative Outcomes in Cardiac Surgery Patients. JAMA. American Medical Association; 1999;281: 2203–2210. doi:10.1001/jama.281.23.2203 39. Lu G, Yan Q, Huang Y, Zhong Y, Shi P. Prevention and control system of hypokalemia in fast recovery after abdominal surgery. Curr Ther Res Clin Exp. 2013;74: 68–73. doi:10.1016/j.curtheres.2013.02.004 40. Lepage R, Légaré G, Racicot C, Brossard JH, Lapointe R, Dagenais M, et al. Hypocalcemia induced during major and minor abdominal surgery in humans. J Clin Endocrinol Metab. 1999;84: 2654–2658. doi:10.1210/jcem.84.8.5889 41. Li X, Gao Y, Xu H, Hou J, Gao P. Diabetes mellitus is a significant risk factor for the development of liver cirrhosis in chronic hepatitis C patients. Sci Rep. 2017;7: 9087. doi:10.1038/s41598-017-09825-7 42. Shau W-Y, Shao Y-Y, Yeh Y-C, Lin Z-Z, Kuo R, Hsu C-H, et al. Diabetes mellitus is associated with increased mortality in patients receiving curative therapy for hepatocellular carcinoma. Oncologist. 2012;17: 856–862. doi:10.1634/theoncologist.2012-0065 43. Tolman KG, Fonseca V, Dalpiaz A, Tan MH. Spectrum of liver disease in type 2 diabetes and management of patients with diabetes and liver disease. Diabetes Care. 2007;30: 734–743. doi:10.2337/dc06-1539 44. Gommers LMM, Hoenderop JGJ, Bindels RJM, de Baaij JHF. Hypomagnesemia in Type 2 Diabetes: A Vicious Circle? Diabetes. 2016;65: 3–13. doi:10.2337/db15-1028 45. Kuo C-S, Chen Y-T, Hsu C-Y, Chang C-C, Chou R-H, Li S-Y, et al. The impact of chronic hepatitis B infection on major adverse cardiovascular events and all-cause mortality in patients with diabetes: a nationwide population-based study from Taiwan. BMJ Open. 2017;7: e016179. doi:10.1136/bmjopen-2017-016179 46. Huang M-Y, Chung C-H, Chang W-K, Lin C-S, Chen K-W, Hsieh T-Y, et al. The role of thiazolidinediones in hepatocellular carcinoma risk reduction: a population-based cohort study in Taiwan. Am J Cancer Res. 2017;7: 1606–1616. Available: 47. Qavi AH, Kamal R, Schrier RW. Clinical Use of Diuretics in Heart Failure, Cirrhosis, and Nephrotic Syndrome. Int J Nephrol. Hindawi; 2015;2015. doi:10.1155/2015/975934 48. Greenway DC, Hindmarsh JT, Wang J, Khodadeen JA, Hébert PC. Reference interval for whole blood ionized magnesium in a healthy population and the stability of ionized magnesium under varied laboratory conditions. Clin Biochem. 1996;29: 515–520. doi:10.1016/s0009-9120(96)00091-4 49. D'Antonio A, Caleo A, Caleo O, Addesso M, Boscaino A. Hepatocellular carcinoma metastatic to the kidney mimicking renal oncocytoma. Hepatobiliary Pancreat Dis Int. 2010;9: 550–552. Available: 50. Zhang W, Sun B. Impact of age on the survival of patients with liver cancer: an analysis of 27,255 patients in the SEER database. Oncotarget. 2015;6: 633–641. doi:10.18632/oncotarget.2719
摘要: 簡介: 鎂,鉀和鈣離子會影響心肌細胞的電氣生理活動,心臟的傳導系統和心肌收縮力。接受主要手術的病人的血鉀,鈣和鎂水平對手術週期管理及其預後非常重要。 材料和方法: 在此一回顧性研究中,我們評估了接受肝臟手術的患者基礎低鎂血症比例是否大於其他主要手術。此外病使用病例對照設計,以1:3的比例選取非肝臟手術對照組,研究肝臟手術病人血液氣體分析之各項結果[1]。我們還調查了肝臟手術中基礎低鎂血症的預測因素。 結果: 與非肝臟手術患者相比,肝臟手術患者基礎低鎂血症的發生率更高(45.0% vs 29.6%,p <0.001)。年齡<65歲,術前葡萄糖> 250 mg/dL,基礎Ca ++ <1.13 mmol/L被確定為肝臟手術患者基線低鎂血症的預測因子。 結論: 常規術前檢查未檢查血清鎂水平。可能有必要在這些患者中包含血清鎂測量。 關鍵字: 低血鎂、肝臟手術
Background: Magnesium, potassium and calcium affect the electrical activity of myocardial cells, the specialized conducting system of the heart, and myocardial contractility[2]. Blood levels of potassium, calcium and magnesium in patients undergoing major surgery are very important for perioperative management and outcomes. Materials and methods: In the retrospective study, we assessed whether the proportion of baseline hypomagnesemia in patients undergoing liver surgery was greater than that in the other major surgery. Furthermore, compared with non-liver surgery, the risk of preoperative hyperglycemia and baseline hypomagnesemia in liver surgery were determined using the case-control design with a ratio 1:3[1]. We also investigated the predictors of baseline hypomagnesemia in liver surgery. Results: Higher incidence of baseline hypomagnesemia in liver surgery patients was observed compared with non-liver ones (45.0% VS. 29.6%, p < 0.001). In patients with age < 65, preoperative glucose >= 250 mg/dL and baseline Ca++ < 1.13 mmol/L were identified as predictors of baseline hypomagnesemia in liver surgery patients. Conclusion: Serum magnesium levels are not examined in routine preoperative checkup. It may be necessary to include serum magnesium measurement in these patients. Keyword: hypomagnesemia, liver surgery
文章公開時間: 2020-08-22
Appears in Collections:食品暨應用生物科技學系



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.